During the reinspection, the production conditions at the Company’s 11 sites manufacturing sterile and non-sterile medicinal products, including four new production sites, were audited.
Farmak JSC is expecting the inspection report within the term established by the Croatian laws.
The positive result of the reinspection will facilitate Farmak’s expansion to the European markets.
According to the notice of the State Service of Ukraine on Medicines and Drug Control, “The passing of such procedure and the extension of the GMP certificate validity for Farmak, a Ukrainian manufacturer, is a confirmation of the quality of medicinal products manufactured by the Company, as well as their marketing authorizations”.
Previous inspections by HALMED, the Croatian regulatory agency, were conducted at Farmak JSC in 2015. Following the inspections, the Company obtained the corresponding GMP certificates.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...